Skip to content

To evalute The efficacy Of Apamarga Kshara Prateesarana Followed By Mushaka Taila Matrabasti In The Management Of Gudabhramsha (Partial Rectal Prolapse)

A Clinical Study Of Apamarga Kshara Prateesarana Followed By Mushaka Taila Matrabasti In The Management Of Gudabhramsha (Partial Rectal Prolapse) - NO

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034988
Enrollment
30
Registered
2021-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K623- Rectal prolapse

Interventions

Intervention1: application of Apamarga prateesarana kshara followed by mushaka taila matrabasti: Apamarga kshara prateesaran application will be done on partial rectal prolapse will be followed by Mu

Sponsors

Government Akhandanand Ayurved Mahavidhyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The length of partial prolapse is not more than 3.75 cm patient having confirmed diagnosis of partial rectal prolapse controlled case of diabetes mellitus and hypertension

Exclusion criteria

Exclusion criteria: patient below 18 year and above 80 year contraindicated for kshara karma uncontrolled case of diabetes mellitus and hypertension any type of coagulopathy viz haemophilia sickle cell anaemia HIV and HBsAG patient and any carcinoma of the rectum anal canal .

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of decrease size and symptoms of rectal prolapseTimepoint: 22 days

Secondary

MeasureTime frame
To assess the clinical efficacy of apamarga kshara prateesarana followed by mushaka taila matrabasti in the management of rectal prolapse .Timepoint: 22 days

Countries

India

Contacts

Public ContactDr Harshit Shah

Government Akhandanand Ayurved College

akhandanandprincipal@gmail.com9824068760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026